Applied Materials, Inc.Download PDFPatent Trials and Appeals BoardApr 2, 20212020003192 (P.T.A.B. Apr. 2, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/000,857 01/19/2016 Kwangduk Douglas LEE 016078/USAC02/ DSM/BCVD/AG 5949 44257 7590 04/02/2021 PATTERSON & SHERIDAN, LLP - - APPLIED MATERIALS 24 GREENWAY PLAZA SUITE 1600 HOUSTON, TX 77046 EXAMINER COLEMAN, RYAN L ART UNIT PAPER NUMBER 1714 NOTIFICATION DATE DELIVERY MODE 04/02/2021 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): Pair_Eofficeaction@pattersonsheridan.com psdocketing@pattersonsheridan.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte KWANKGDUK DOUGLAS LEE, SUDHA RATHI, RAMPRAKASH SANKARAKRISHNAN, MARTIN JAY SEAMONS, IRFAN JAMIL, and BOK HOEN KIM Appeal 2020-003192 Application 15/000,857 Technology Center 1700 Before ADRIENE LEPIANE HANLON, GEORGIANNA W. BRADEN, and SHELDON M. MCGEE, Administrative Patent Judges. MCGEE, Administrative Patent Judge. DECISION ON APPEAL Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1–20. We have jurisdiction. 35 U.S.C. § 6(b). We affirm. 1 We use the word “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies the real party in interest as Applied Materials, Inc. Appeal Br. 3. Appeal 2020-003192 Application 15/000,857 2 CLAIMED SUBJECT MATTER The claims are directed to methods of dry-stripping films containing carbon and boron using oxygen-containing and hydrogen-containing plasma. Appeal Br. 13–16 (Independent Claims 1, 9, 15); Spec. ¶ 2. Claim 1 is illustrative of the claimed subject matter, and is reproduced below with a key limitation on appeal italicized for emphasis: 1. A method for stripping a film from a substrate, comprising: positioning a substrate having the film thereon in a chamber, the film comprising boron and carbon; providing an oxygen-containing plasma in the chamber; exposing the film to the oxygen-containing plasma to generate one or more volatile compounds from the boron and carbon; providing an hydrogen-containing plasma in the chamber; exposing the film to the hydrogen-containing plasma to generate one or more volatile compounds from the boron and carbon; exhausting the oxygen-containing plasma from the chamber while continuing to provide the hydrogen-containing plasma; and exhausting at least one of the one or more volatile compounds from the chamber. STATEMENT OF THE CASE The Examiner rejects claims 1–20 under 35 U.S.C. § 103(a) over the combined disclosures of Wang,2 Sin,3 Gouk,4 and Liebau,5 with or without additional prior art. Final Act. 3–22. Regarding claim 1, the Examiner finds that Wang teaches a method of stripping a film containing carbon and boron 2 US 2005/0202683 A1, published September 15, 2005. 3 US 2007/0107749 A1, published May 17, 2007. 4 US 2011/0143170 A1, published June 16, 2011. 5 US 2009/0045161 A1, published February 19, 2009. Appeal 2020-003192 Application 15/000,857 3 by providing oxygen-containing and hydrogen-containing plasmas. Final Act. 3. The Examiner finds that while Wang does not explicitly disclose that the oxygen- and hydrogen-containing plasmas generate one or more volatile compounds from the boron and carbon, it would have been reasonably expected to occur. Id. at 4. The Examiner also finds that Wang does not disclose exhausting the volatile compounds from the chamber as claimed. To address this difference, the Examiner turns to Sin, which the Examiner undisputedly finds discloses such exhaustion. Id. The Examiner determines it would have been obvious to modify Wang’s method by exhausting the volatile compounds away from the treated substrate to avoid contaminating the treated substrate’s surface. Id. at 5. The Examiner finds further that Wang and Sin do not teach exhausting the oxygen-containing plasma from the chamber while continuing to provide the hydrogen-containing plasma as recited in claim 1. Id. To address this difference, the Examiner turns to Gouk and Liebau. Id. at 5–6. Specifically, the Examiner finds Gouk evinces that, post-etch, a hydrogen plasma can be used to remove “any remaining undesired material on the surface of the substrate” and that such removal “can be performed by replacing the flow of first plasma constituent gases” with that of the second, hydrogen plasma. Id. at 5. The Examiner also finds Liebau evinces “that a hydrogen-comprising plasma can successfully be used to etch away carbon from a substrate.” Id. at 5–6. Based on these disclosures, the Examiner determines it would have been obvious to modify the method of Wang as modified by Sin, to continue providing hydrogen-containing plasma after exhausting the oxygen-containing plasma in order to “advantageously Appeal 2020-003192 Application 15/000,857 4 allow[] etching products to be removed and allow[] the continued hydrogen plasma to etch away any remnants of carbon.” Id. at 6. OPINION We review the appealed rejections for reversible error based on the arguments and evidence presented by Appellant. 37 C.F.R. § 41.37(c)(1)(iv); Ex parte Frye, 94 USPQ2d 1072, 1075 (BPAI 2010) (precedential) cited with approval in In re Jung, 637 F.3d 1356, 1365 (Fed. Cir. 2011) (explaining that even if the Examiner had failed to make a prima facie case, “it has long been the Board’s practice to require an applicant to identify the alleged error in the examiner’s rejections”). Appellant only provides arguments directed to the Examiner’s rejection of independent claims 1, 9, and 15. Appeal Br. 7–11; Reply Br. 2– 9. Appellant relies on the same arguments presented as to claims 1, 9, and 15 in asserting that the rejections of claims 2–8, 10–14, and 16–20 are likewise improper. Appeal Br. 11. In accordance with 37 C.F.R. § 41.37(c)(1)(iv), and based upon the lack of arguments directed to the subsidiary rejections, claims 2–8, 10–14, and 16–20 will stand or fall together with the independent claims. Having reviewed the appeal record, we affirm the obviousness rejections for the reasons provided by the Examiner. Final Act. 3–27; Ans. 3–10. We add the following primarily for emphasis. Appellant argues that Wang does not disclose a film comprising carbon and boron. Appeal Br. 7–8; Reply Br. 2–4. While Appellant is correct that Wang does not expressly state that the resultant film contains carbon and boron when a boron-containing derivative of a hydrocarbon compound is used (Wang ¶ 25), such express disclosure is not required to Appeal 2020-003192 Application 15/000,857 5 establish a finding of fact. In re Preda, 401 F.2d 825, 826 (CCPA 1968) (“in considering the disclosure of a reference, it is proper to take into account not only specific teachings of the reference but also the inferences which one skilled in the art would reasonably be expected to draw therefrom”). Here, the Examiner finds that the skilled artisan would have understood that Wang’s films would contain carbon and boron if a boron- containing derivative of the hydrocarbon was used to prepare the film. Final Act. 25. That finding is sufficiently supported. Wang discloses that “[a]n amorphous carbon layer may be deposited by a process including introducing a gas mixture of one or more hydrocarbon compounds.” Wang ¶ 24. Wang then discloses that doped derivatives such as “boron-containing derivatives of the hydrocarbon compounds as well as fluorinated derivatives” can be used as an alternative to the hydrocarbon. Id. ¶ 25. Wang provides further detail regarding possible fluorinated derivatives which may be used and what the resultant layer would be––“a fluorinated amorphous carbon layer, which may be described as an amorphous fluorocarbon layer.” Id. (emphasis added). In other words, using the fluorinated derivative of the hydrocarbon yields a layer containing carbon and fluorine. Despite Wang’s comparative lack of detail regarding boron- containing derivatives vis-à-vis fluorinated derivatives, the skilled artisan would have reasonably inferred from Wang’s disclosure that the layer would contain carbon and boron if a boron-containing derivative was used. In addition, the Examiner’s findings sufficiently establish that Wang’s film inherently contains boron if a boron-containing derivative is used in its preparation. “The inherent teaching of a prior art reference [is] a question of fact.” In re Napier, 55 F.3d 610, 613 (Fed. Cir. 1995). “[T]o rely on Appeal 2020-003192 Application 15/000,857 6 inherency to establish the existence of a claim limitation in the prior art in an obviousness analysis[,] the limitation at issue necessarily must be present, or the natural result of the combination of elements explicitly disclosed by the prior art.” PAR Pharm., Inc. v. TWI Pharms., Inc., 773 F.3d 1186, 1195–96 (Fed. Cir. 2014). An inherency finding must be supported by factual evidence and must also be directed to the claim limitation at issue. See Napier, 55 F.3d at 613 (discussing the evidence relied on by the Board to establish the prior art’s inherent disclosure of “redirection of noise”); cf. PAR, 773 F.3d at 1196 (faulting the district court’s analysis for not tying the evidence presented to the recited claim limitation of “no substantial difference in Cmax”). Here, the Examiner has provided ample evidence supporting a finding that the natural result of using Wang’s boron-containing hydrocarbon derivative to deposit the amorphous carbon layer would be a layer containing carbon and boron as required by the claims. Final Act. 25; Ans. 3–5; Wang ¶¶ 24–25. And “when the PTO shows sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not.” In re Spada, 911 F.2d 705, 708 (Fed. Cir. 1990). Appellant has made no such showing on this record. We likewise are unpersuaded by Appellant’s contentions directed to the limitation requiring “exhausting the oxygen-containing plasma from the chamber while continuing to provide the hydrogen-containing plasma.” Appeal Br. 9–10. Contrary to Appellant’s argument, the Examiner relies on the combined disclosures of Gouk and Liebau, not on Gouk alone, to establish why this limitation would have been obvious. Compare Final Act. 5–6, with Appeal Br. 9 (“the Examiner relies on Gouk to disclose the Appeal 2020-003192 Application 15/000,857 7 missing elements”). Appellant’s focus on Gouk’s teachings to the exclusion of Liebau does not fully address the substance of the rejection and, therefore, fails to identify reversible error. We also disagree with Appellant’s argument that the Examiner failed to provide a reason to modify the combination of Wang, Sin, Gouk, and Liebau with the teachings of the Yin reference (Appeal Br. 9; Reply Br. 4–5) or the Kaveh and/or Miya references (Appeal Br. 11; Reply Br. 6). As the Examiner makes clear in the Answer, the Yin reference was merely relied on as an evidentiary reference to demonstrate one example of boron-doped carbon layers. Ans. 6–7; See Final Act. 24–25 (stating that Yin is cited “simply for greater (but unnecessary) clarity” to explain “how boron-doped amorphous carbon films are formed”). Similarly, Kaveh and Miya are not part of a rejection, but serve as evidence supporting the Examiner’s findings based on Official Notice. Final Act. 23; Ans. 8–9. The Examiner need not provide a rationale to modify the relied-upon prior art with such evidentiary references. Finally, we discern no persuasive merit in Appellant’s traversal of the Examiner’s use of Official Notice to establish it was well known to handle a substrate in a clean environment to avoid contamination of the substrate’s surface. Appeal Br. 10. Appellant does not explain, nor do we discern, how the relied upon evidentiary reference Kaveh fails to evince the officially noticed fact. Id.; Final Act. 23; Kaveh, 1:20–34; see MPEP 2144.03C (explaining that an adequate traversal of an officially noticed fact “must specifically point out the supposed errors in the examiner’s action, which would include stating why the noticed fact is not considered to be common knowledge or well-known in the art.” (emphasis added)). In fact, Appellant’s statement that “clean environments can be desirable in some Appeal 2020-003192 Application 15/000,857 8 circumstances while processing substrates in the electronics industry” undermines Appellant’s traversal and supports the Examiner’s reliance on Official Notice here. Appeal Br. 10. We, therefore, sustain the rejections of claims 1–20 for the reasons expressed by the Examiner and above. CONCLUSION The Examiner’s rejections are affirmed. DECISION SUMMARY Claim(s) Rejected 35 U.S.C. § References / Basis Affirmed Reversed 1, 8, 9, 12, 14, 15, 20 103(a) Wang, Sin, Gouk, Liebau 1, 8, 9, 12, 14, 15, 20 2 103(a) Wang, Sin, Gouk, Liebau, Nguyen 2 3 103(a) Wang, Sin, Gouk, Liebau, Qingyuan 3 4–7 103(a) Wang, Sin, Gouk, Liebau, Huang 4–7 10–11 103(a) Wang, Sin, Gouk, Liebau, Nguyen 10–11 13 103(a) Wang, Sin, Gouk, Liebau, Huang 13 16–18 103(a) Wang, Sin, Gouk, Liebau, Nguyen 16–18 19 103(a) Wang, Sin, Gouk, Liebau, Huang 19 Overall Outcome 1–20 Appeal 2020-003192 Application 15/000,857 9 TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation